Collaboration With the World Health Organization and its Regional Offices for Global Health Security and the International Health Regulations (IHR 2005)

 

On September 19, 2011, the Government of the United States of America and the World Health Organization (WHO) signed a memorandum of understanding (MOU) to help WHO Member States strengthen their capabilities to support the International Health Regulations (IHR), an international agreement that requires Member States to prevent and respond to acute public health risks that have the potential to cross borders. The MOU includes specific statements that authorize WHO and its regional offices to pursue activities that improve the ability of all nations to detect, report, and respond to infectious diseases quickly and accurately. The purpose is to assist WHO in implementing the MOU regarding the International Health Regulations, including the development and implementation of coordinated plans and networks that enable national governments and regional authorities globally to better address infectious diseases, particularly emerging infections. Specific activities will focus on improving infectious disease surveillance and response; enhancing knowledge generation, innovation, and tools for improved management that build public health infrastructure and strengthen regional health leadership and collaboration; sharing knowledge, tools and other resources in support of applied epidemiology; and developing improved infectious disease surveillance, prevention and control strategies.

Active 93.099 Centers For Disease Control and Prevention, Department of Health and Human Services B - Project Grants Not applicable. Public Health Service Act, Section 301(a) and 307 as amended [42 U.S.C. §§ 241 and 2421], 42 USC 287b, 31 USC 6305, 42 CFR 63a. Only the World Health Organization and its regional offices are eligible to apply. For purposes of this document, the term "WHO" includes its regional offices (e.g., PAHO, EMRO, AFRO, SEARO, etc). WHO is the only international and intergovernmental agency qualified to conduct activities under this cooperative agreement. The World Health Organization and its regional offices work will benefit individuals worldwide, including in the U.S., through collaboration with National Ministries of Health and other organizations/institutions. The purpose is to support WHO to reduce the global disease burden through improved international capacity to detect, respond to, prevent and control infectious diseases and other threats. Any required credentials and/or documentation will be identified in the specific Notice of Funding Opportunity (NOFO) for this Assistance Listing. Preapplication coordination is not applicable. 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Applicants must download and submit the SF424 application package associated with specific Notice of Funding Opportunity (NOFO) issued by CDC via Grants.gov. Specific application instructions will be included in the NOFO. Applications are not solicited nor will they be accepted outside of a published NOFO process. After review and approval, a Notice of Award (NoA) will be prepared and processed, along with appropriate notification to the public. Initial awards provide funds for the first budget period (usually 12 months) and the NoA will indicate support recommended for the remainder of the project period, allocation of Federal funds by budget categories, award requirements, and special conditions, if any. Contact the headquarters or regional location, as appropriate for application deadlines From 30 to 60 days. Not applicable. Awards under this Program are typically issued for 1- to 5-year project periods. Renewals at the end of each project period are expected to be made available via publishing of a new/continuation NOFO with a complete application and review/award process as described above. Annual renewals within an awarded multi-year project period are made via a non-competitive process. Applications are reviewed against specific Evaluation Criteria published in the Notice of Funding Opportunity(NOFO) under this program. Evaluation Criteria typically evaluates how well the application demonstrates or illustrates quality, experience, etc., in the areas of background/understanding of the public heatlh problem(s), operational plan, technical approach, plan for evaluation and monitoring, staffing, appropriateness of requested budget, etc. Support implementation of the IHR by analyzing regional, national, and local resources devoted to infectious diseases and identifying areas for implementation of infectious disease activities consistent with the purpose of this cooperative agreement. Develop, implement, and conduct projects to enhance infectious disease surveillance, response, prevention, and control. Srengthen regional and national public health networks and inter-sectorial co-operation and collaborate with other health organizations, academic institutions, and community groups as appropriate to accomplish program activities. Strengthen regional and national public health leadership and collaboration. Monitor and evaluate overall program performance and the progress of individual projects or activities. Publish and disseminate findings, program evaluations, and lessons learned. Performance Reports: Annual Federal Financial Reports (FFR) and performance/progress reports are required. Final FFRs and performance reports are required. Other reporting may be required and will be outlined in the NOFO or the Notice of Award. In addition, grants and cooperative agreements are subject to inspection and audits by DHHS and other Federal government officials. In accordance with 2 CFR ?200, as codified in 45 CFR ?75, there is a 3-year record retention requirement; records shall be retained beyond the 3-year period if final audit has not been done or findings resolved. Property records must be retained in accordance with HHS Grants Policy Statement requirements. Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing. Financial assistance is provided for a 12-month budget period with a period of performance of up to five years subject to the availability of funds and satisfactory progress of the recipient. Notice of Award None/Not specified. Yvette Valentine
1600 Clifton Rd. NE Mail stop H21-9
Atlanta, GA 30333 USA
ybt0@cdc.gov
Phone: 404-639-4469

Carla (Casey) Boudreau
1600 Clifton Rd. NE
Mail stop H21-9
Atlanta, GA 30333 USA
znc5@cdc.gov
Phone: 4046398404 http://www.cdc.gov 75-0943-0-1-550 (Cooperative Agreements) FY 22$79,066,324.00; FY 23 est $19,600,000.00; FY 24 est $25,000,000.00; FY 21$57,501,169.00; FY 20$28,617,539.00; FY 19$85,248,580.00; FY 18$49,378,834.00; FY 17 Estimate Not Available FY 16$4,288,312.00; - Range: $19,000,000 - $70,000,000; Average: $39,724,488 Regulations governing this program are published in the specific Notice of Funding Opportunity Announcements and identified on the Notices of Award. Not applicable.